异常性胃的背景因素和最佳治疗方法:一个多中心的回顾性日本研究
Noriyuki Nakajima1, Toshihisa Takeuchi2, Ryota Hokari3
1Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi Takatsuki, Osaka 569-8686, Japan.
不能愈合的异常性胃潰瘍可能與酸性過分泌有關. 胃粘膜缩的缺失和胃状腺息肉的存在在耐火病例中更为常见,这表明了新的治疗途径.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 在近一半的患者中,异形性胃潰瘍缺乏典型的危險因子.
- 了解耐火性异常性胃潰瘍是有效治療的關鍵.
- 识别不愈合的的独特特征可以指导治疗策略.
研究的目的:
- 为了调查异常性胃潰瘍的趨勢.
- 为了表征耐火性异常性胃潰瘍.
- 为了确定异常性胃潰瘍的最佳治疗策略.
主要方法:
- 检查了309名患有异常性胃潰瘍的患者的特征.
- 将分类为耐火性 (8周后未愈合) 或已愈合.
- 在不同组之间比较患者人口统计,风险因素和治疗反应.
主要成果:
- 胃粘膜缩的缺失和胃状腺息肉的存在在耐火组中更为频繁.
- 在治愈组中,H. pylori根除史和先前的H. pylori感染更为常见.
- 在治愈组中,与竞争的酸阻塞剂的使用量明显高于治愈组.
结论:
- 酸过分分泌可能是异常性胃潰瘍的折射性的主要因素.
- 胃粘膜缩和H. pylori病史与的愈合有关.
- 对酸抑制疗法的进一步研究可能会使耐火性异常性胃潰瘍患者受益.
更多相关视频
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
相关概念视频
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
